𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Does fluoxetine aggravate Parkinson's disease? A pilot prospective study

✍ Scribed by Jean-Louis Montastruc; Nelly Fabre; Olivier Blin; Jean-Michel Senard; Olivier Rascol; André Rascol


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
366 KB
Volume
10
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Bright light therapy in Parkinson's dise
✍ Sebastian Paus; Tanja Schmitz-Hübsch; Ullrich Wüllner; Antje Vogel; Thomas Klock 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 2 views

## Abstract Several observations suggest a beneficial effect of melatonin antagonism for Parkinson's disease (PD). Although bright light therapy (BLT) suppresses melatonin release and is an established treatment for depression and sleep disturbances, it has not been evaluated in PD. We examined eff

Ethosuximide and tremor in Parkinson's d
✍ E. Pourcher; B. Gomez-Mancilla; Dr. P. J. Bédard 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 1 views

## Abstract Following the demonstration of an antitremor effect of ethosuximide in the 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) monkey model, we have tested the effect of this drug in 10 patients with typical parkinsonian tremor. Six patients suffered from Parkinson's disease with promin

Excess burden of constipation in Parkins
✍ Julie Kaye; Heather Gage; Alan Kimber; Lesley Storey; Patrick Trend 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

An analysis was undertaken of clinic-based questionnaires that asked people with Parkinson's disease and a control group of older people without a known neurological condition about their experiences of constipation. People with Parkinson's disease report higher constipation on a validated objective

Mortality from Parkinson's disease: A po
✍ Ignacio J. Posada; Julián Benito-León; Elan D. Louis; Rocío Trincado; Alberto Vi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 1 views

## Abstract Most studies of mortality in Parkinson's disease have been clinical studies, yielding results that are not representative of the general population. We assessed the risk of mortality from Parkinson's disease in the Neurological Disorders in Central Spain (NEDICES) study, a prospective p

Rate of clinical progression in Parkinso
✍ Anette Schrag; Richard Dodel; Annika Spottke; Bernhard Bornschein; Uwe Siebert; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract Few prospective data on the clinical progression of Parkinson's disease (PD) in patient groups outside treatment trials in selected patients are available, and controversy exists on the rate of clinical disease progression with advancing disease. In this study, we investigated the rate